Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/cu-medicine-receives-the-li-ka-shing-foundation-s-donation-of-asia-s-first-histotripsy-2-0-system-30-patients-sponsored-to-receive-novel-treatment-for-liver-tumours
https://www.med.cuhk.edu.hk/press-releases/cu-medicine-receives-the-li-ka-shing-foundation-s-donation-of-asia-s-first-histotripsy-2-0-system-30-patients-sponsored-to-receive-novel-treatment-for-liver-tumours

CU Medicine receives the Li Ka Shing Foundation’s donation of Asia’s first Histotripsy 2.0 system 30 patients sponsored to receive novel treatment for liver tumours

The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine) has received Asia’s first Histotripsy 2.0 system as a donation from the Li Ka Shing Foundation (Foundation) which is serving patients in early 2025. Equipped with state-of-the-art hardware, Histotripsy 2.0 can accommodate more functions and support continuous system and software upgrades while offering more comprehensive and specific data that enable more precise focal therapy.  The Foundation will sponsor 10 patients to receive this novel treatment, while CU Medicine and the Prince of Wales Hospital (PWH) Charitable Foundation will support another 20 patients, CU Medicine and PWH will lead clinical trials of Histotripsy for 30 liver cancer patients. The multi-disciplinary team of CU Medicine and PWH will commence clinical research to advance the application of Histotripsy to cancer treatment beyond liver tumours.

 

Enhancement of Histotripsy 2.0:

  1. Equipped with state-of-the-art hardware, accommodating more functions and supporting continuous system and software updates
  2. Offering more comprehensive and specific data
  3. Enabling more precise focal therapy
Group Photo

CU Medicine receives the donation of Asia’s first Histotripsy 2.0 system from the Li Ka Shing Foundation. CU Medicine and PWH will lead clinical trials of Histotripsy for 30 liver cancer patients in early 2025.
 

(From left) Dr Chung Kin-lai, Cluster Chief Executive of New Territories East and Hospital Chief Executive, Prince of Wales Hospital; Professor Anthony Chan Tak-cheung, Li Shu Fan Medical Foundation Professor of Clinical Oncology and CUHK’s Pro-Vice-Chancellor; Dr Joseph Herman, Chief Medical Officer, HistoSonics; Professor Dennis Lo Yuk-ming, Li Ka Shing Professor of Medicine and CUHK’s Vice-Chancellor Designate; Professor Zhen Xu, Professor of Biomedical Engineering, University of Michigan and main inventor of Histotripsy; Mr Mike Blue, President and CEO of HistoSonics; Professor Philip Chiu Wai-yan, Shun Hing Education and Charity Fund Professor of Robotic Surgery andDean of CU Medicine; Professor Simon Ng Siu-man, Wei Lun Professor of Surgery and Chairman, Department of Surgery, CU Medicine; Professor Winnie Chu Chiu-wing from CU Medicine’s Department of Imaging and Interventional Radiology; and Professor James Griffith, Chairman, Department of Imaging and Interventional Radiology, CU Medicine at the press conference.

The Asia’s first Histotripsy 2.0 enables more precise focal therapy 
Mr Li and Professor Lo

Mr Li Ka-shing, Chairman of the Li Ka Shing Foundation and Professor Dennis Lo,Li Ka Shing Professor of Medicine and Vice-Chancellor Designate of CUHK exchange thoughts on the donation of Histotripsy 2.0 via videoconferencing. Mr Li hopes that cost-effective and efficient medical technologies can significantly improve healthcare quality and develop a healthcare economy that serves Hong Kong, mainland China and Southeast Asia. Professor Lo expresses gratitude for Mr Li’s support of CUHK over the years and undertakes that CUHK will make this world’s leading, novel technology accessible to patients as soon as possible through studies and research.

Professor Dennis Lo,Li Ka Shing Professor of Medicine and Vice-Chancellor Designate of CUHK, thanked Mr Li Ka-shing and the Foundation for their support to CUHK.  “As early as 2005, Mr Li made a substantial donation to establish the Li Ka Shing Institute of Health Sciences at CUHK.  It has been my privilege to be the founding director and lead the Institute since then to chart a new course in medical research for the University, the Hong Kong community, and the wider Asian region.  I am deeply honoured to serve as the ninth Vice-Chancellor and President of CUHK, and look forward to the continuous support of Mr Li and the Foundation to further CUHK’s contributions to education and research locally, nationally and globally.”   

 

Professor Anthony Chan, Li Shu Fan Medical Foundation Professor of Clinical Oncology and  Pro-Vice-Chancellor of CUHK, expressed gratitude to the Foundation: “Over the years, Mr. Li Ka-shing and the Foundation have always been supportive of CUHK's education and research development, and have made generous donations to support many CUHK's units and departments.  The donation of Histotripsy will strengthen CUHK's clinical research capacity in cancer treatment and enable more patients to benefit from the world's cutting-edge medical technology.”

 

Professor Philip Chiu Wai-yan, Shun Hing Education and Charity Fund Professor of Robotic Surgery and Dean of CU Medicine stated: ‘‘We would like to express our sincere appreciation to Mr Li Ka-shing for the support to CU Medicine over the years, which have empowered us to scale new heights in medical innovation. CU Medicine has long been a pioneer in the research, development and introduction of state-of-the-art medical technology and devices. We aspire to provide patients with innovative clinical solutions, enabling safer and more effective treatment through multi-disciplinary collaboration. We are also very grateful for the donation from the Prince of Wales Hospital Charitable Foundation and the support of the PWH team in making histotripsy accessible to more patients.’’  

 

Mr Li Ka-shing stated: “Since the first Histotripsy system arrived in Hong Kong, treatment for 30 patients with liver cancer has been successfully arranged in 90 days.  This game-changing technology is a gift of hope, health and life. The promise and impact of this low cost, high efficacy option tremendously lessened the financial devastation on the patients and their families, and more importantly, the fiscal burden to the government health care services in our ageing society.”

 

Histotripsy 2.0 is equipped with next-generation hardware, capable of accommodating more functions by enabling continuous system and software upgrades. The system will enable even more efficient tumour ablation by providing more objective and continuous feedback of the ablation process, laying a solid foundation for the treatment of multiple kinds of cancer with the extended use of Histotripsy across different parts of the body.

 

Professor Zhen Xu

Featured is Professor Zhen Xu, Professor of Biomedical Engineering, University of Michigan and the main inventor of Histotripsy, with the Histotripsy system.

A new horizon for the treatment of multiple cancers enabled by breakthrough technology and multi-disciplinary efforts

 

Professor James Griffith, Chairman of CU Medicine’s Department of Imaging and Interventional Radiology, reflected that: “Histotripsy uses high-intensity ultrasound waves to disrupt and liquefy targeted tumour cells. Treatment takes as little as 10-15 minutes without damaging important surrounding tissues. No surgery is required, making it a safe, non-invasive and highly effective treatment option. For all medical specialities, personalised, precise treatment is the ultimate goal. Histotripsy is a timely non-surgical approach to cancer treatment, providing patients with an additional option that can destroy tumours in a targeted manner.’’

 

Professor Simon Ng Siu-man, Wei Lun Professor of Surgery and Chairman of the Department of Surgery at CU Medicine, added: ‘‘A CUHK-PWH clinical team has already successfully applied this novel technology in treating a patient with liver cancer, which demonstrated good post-operative recovery and satisfactory efficacy. Gathering experts from the Departments of Clinical Oncology, Surgery, and Imaging and Interventional Radiology, CU Medicine’s multi-disciplinary team is ready to study how this innovative technology can be adopted for the treatment of common cancers in Hong Kong, such as breast cancer.’’   

 

Professor James Griffith and Professor Simon Ng

Professor Simon Ng Siu-man, Wei Lun Professor of Surgery and Chairman, Department of Surgery, CU Medicine and Professor James Griffith, Chairman, Department of Imaging and Interventional Radiology, CU Medicine share how the technology of Histotripsy treats liver cancer patients and cite how CUHK-PWH team applied this novel technology in treating a patient with liver cancer.

Histotripsy shows tremendous potential in breast cancer treatment 

 

According to the Hong Kong Cancer Statistics of 2022, breast cancer is the second most common cancer in Hong Kong. It is also the most common cancer type affecting women of most age groups. Lifetime breast cancer risk is one in every 14 Hong Kong women.         

 

In recent years, the medical field has been hotly looking into the use of “focal therapy” as the future direction for breast cancer treatment, providing patients with treatment options other than surgery. Focal therapy is potentially suitable for early-stage breast cancer patients with small tumours without lymphatic spread. The advantages include the use of only local anaesthesia, and the ability to perform the procedure in an outpatient setting, resulting in quicker recovery and well-maintained breast appearance without surgical scars. It is non-toxic and can be used in conjunction with other treatments.

 

Professor Winnie Chu Chiu-wing from the Department of Imaging & Interventional Radiology of CU Medicine recognises that Histotripsy offers a highly desirable approach to breast cancer treatment: ‘‘Histotripsy therapy relies on ultrasound to localise cancer, which is particularly favourable to Asian and Chinese women who have a higher breast density than Caucasian women. Small breast cancers may not be detected by conventional mammography but can be identified through ultrasound. With further technical development, Histotripsy using high-intensity ultrasound waves can potentially be a promising emerging focal therapy option for offering a less invasive option for breast cancer patients who are not suitable for surgery or who decline traditional surgeries such as a mastectomy.”

 

Professor Winnie Chu

With Histotripsy showcasing great precision in creating a heart-shape tissue with high-intensity ultrasound waves in the demonstration, Professor Winnie Chu Chiu-wing from CU Medicine’s Department of Imaging and Interventional Radiology recognises that with further technical development, Histotripsy can potentially be a promising emerging focal therapy option for offering a less invasive option for breast cancer patients.

More Press Releases

CUHK Successfully Performed World’s First Colorectal Endoscopic Submucosal Dissection  Using Flexible Endoscopic Robotic System

CUHK Successfully Performed World’s First Colorectal Endoscopic Submucosal Dissection Using Flexible Endoscopic Robotic System

Surgical advancement
CUHK Successfully Conducted the World’s First Multi-Specialty Clinical Trial Using the Next Generation Single Port Robotic Surgical System

CUHK Successfully Conducted the World’s First Multi-Specialty Clinical Trial Using the Next Generation Single Port Robotic Surgical System

Surgical advancement
CUHK Establishes Chow Yuk Ho Technology Centre for Innovative Medicine An Interdisciplinary Collaboration to Transfer Biomedical Engineering Research into Clinical Practice

CUHK Establishes Chow Yuk Ho Technology Centre for Innovative Medicine An Interdisciplinary Collaboration to Transfer Biomedical Engineering Research into Clinical Practice

Donation
CU Medicine pioneers the introduction of a novel AI system for detection of early gastric cancers during upper GI endoscopy to increase the detection rate of the disease and facilitate endoscopists’ training

CU Medicine pioneers the introduction of a novel AI system for detection of early gastric cancers during upper GI endoscopy to increase the detection rate of the disease and facilitate endoscopists’ training

International collaboration
CUHK and ETH Zurich successfully conduct world’s first in vivo teleoperated magnetic endoscopy using an animal model, over a distance of 9,300 km between Zurich and Hong Kong

CUHK and ETH Zurich successfully conduct world’s first in vivo teleoperated magnetic endoscopy using an animal model, over a distance of 9,300 km between Zurich and Hong Kong

Surgical advancement
CU Medicine study reveals increasing cognitive activity participation strengthens brain network

CU Medicine study reveals increasing cognitive activity participation strengthens brain network

Research
Inaugural lecture of Shun Hing Education and Charity Fund Professorship in Robotic Surgery by Professor Philip Chiu: Dare to Dream – My Journey from Art, Medicine to Robotics and Translational Research

Inaugural lecture of Shun Hing Education and Charity Fund Professorship in Robotic Surgery by Professor Philip Chiu: Dare to Dream – My Journey from Art, Medicine to Robotics and Translational Research

Awards and honors
CUHK appoints Professor Philip Chiu as Dean of Medicine

CUHK appoints Professor Philip Chiu as Dean of Medicine

Milestone
CUHK Professor Dennis Lo receives the inaugural Tengchong Science Prize

CUHK Professor Dennis Lo receives the inaugural Tengchong Science Prize

Awards and honors
CUHK Professor Dennis Lo elected as member of the Chinese Academy of Sciences

CUHK Professor Dennis Lo elected as member of the Chinese Academy of Sciences

Awards and honors
CUHK receives HK$30 million donation from Mr Li Ka-shing to further enhance artificial intelligence in medical education

CUHK receives HK$30 million donation from Mr Li Ka-shing to further enhance artificial intelligence in medical education

Donation
CUHK study concludes that plasma EBV DNA screening can detect early asymptomatic nasopharyngeal cancer and reflect the risk of future cancer development

CUHK study concludes that plasma EBV DNA screening can detect early asymptomatic nasopharyngeal cancer and reflect the risk of future cancer development

Research
Inauguration of CUHK’s S.H. Ho Research Centre for Infectious Diseases

Inauguration of CUHK’s S.H. Ho Research Centre for Infectious Diseases

Donation
CUHK Professor Dennis Lo Receives the Lasker Award, America’s Top Biomedical Science Prize

CUHK Professor Dennis Lo Receives the Lasker Award, America’s Top Biomedical Science Prize

Awards and honors
Three CU Medicine scholars named in world’s “Top 20 Translational Researchers” Professor Dennis LO receives the honour for the fifth consecutive year

Three CU Medicine scholars named in world’s “Top 20 Translational Researchers” Professor Dennis LO receives the honour for the fifth consecutive year

Awards and honors
CUHK Professor Dennis LO Becomes the First Chinese Scientist to Receive the Royal Medal  for Outstanding Achievements in Biological Sciences

CUHK Professor Dennis LO Becomes the First Chinese Scientist to Receive the Royal Medal for Outstanding Achievements in Biological Sciences

Awards and honors
CUHK World First Shows AI-derived MRI Brain Indices   Aid Clinical Detection of Three Cognitive Disorders at Early Stage

CUHK World First Shows AI-derived MRI Brain Indices Aid Clinical Detection of Three Cognitive Disorders at Early Stage

Research
CUHK Receives HK$30 million Donation from Li Ka Shing Foundation to Enhance Research Space and Facilities at CU Medicine

CUHK Receives HK$30 million Donation from Li Ka Shing Foundation to Enhance Research Space and Facilities at CU Medicine

Donation
CUHK Develops Biohybrid Soft Microrobots with a Rapid Endoluminal Delivery Strategy for Gastrointestinal Diseases

CUHK Develops Biohybrid Soft Microrobots with a Rapid Endoluminal Delivery Strategy for Gastrointestinal Diseases

Research
Two CUHK Scholars Named World’s “Top 20 Translational Researchers” Professor Dennis LO Receives the Honour for the Fourth Consecutive Year

Two CUHK Scholars Named World’s “Top 20 Translational Researchers” Professor Dennis LO Receives the Honour for the Fourth Consecutive Year

Awards and honors
Results of the First 3,500 Participants of the CUHK Jockey Club Multi-Cancer Prevention Programme Demonstrate that “One-stop Multi-Cancer Screening” is Effective

Results of the First 3,500 Participants of the CUHK Jockey Club Multi-Cancer Prevention Programme Demonstrate that “One-stop Multi-Cancer Screening” is Effective

Health Campaign
CUHK Professor Dennis LO Receives 2021 Breakthrough Prize, an Honour Renowned as the “Oscars of Science”

CUHK Professor Dennis LO Receives 2021 Breakthrough Prize, an Honour Renowned as the “Oscars of Science”

Awards and honors
Two CUHK Scholars Named World’s “Top 20 Translational Researchers” Professor Dennis Lo Receiving the Honour for the Third Consecutive Year

Two CUHK Scholars Named World’s “Top 20 Translational Researchers” Professor Dennis Lo Receiving the Honour for the Third Consecutive Year

Awards and honors
CUHK Deepening Ties with World Leading Institutes for Transdisciplinary Medical Robotics Research to Reshape the Future of Diagnosis and Treatment

CUHK Deepening Ties with World Leading Institutes for Transdisciplinary Medical Robotics Research to Reshape the Future of Diagnosis and Treatment

International collaboration
李嘉誠基金會啟動《愛能助》兒童癌症項目 資助兒童罕見癌症 (Chinese version only)

李嘉誠基金會啟動《愛能助》兒童癌症項目 資助兒童罕見癌症 (Chinese version only)

Donation
Professor Dennis LO Being Named as World’s “Top Translational Researchers” for Two Consecutive Years

Professor Dennis LO Being Named as World’s “Top Translational Researchers” for Two Consecutive Years

Awards and honors
CUHK Receives Nearly HKD 78 Million from HKJC to Launch Ophthalmic Programmes for Children’s Eye Care and Ophthalmic Microsurgical Training

CUHK Receives Nearly HKD 78 Million from HKJC to Launch Ophthalmic Programmes for Children’s Eye Care and Ophthalmic Microsurgical Training

Donation
CUHK Pioneers in Introducing Museum-Based Observational Skills into Medical Education

CUHK Pioneers in Introducing Museum-Based Observational Skills into Medical Education

Education
CUHK Research Receives Recognitions by Top Medical Journals

CUHK Research Receives Recognitions by Top Medical Journals

Awards and honors
Two CUHK Medical Professors Winning WuXi PharmaTech Life Science and Chemistry Awards

Two CUHK Medical Professors Winning WuXi PharmaTech Life Science and Chemistry Awards

Awards and honors
CUHK-DGIST-ETH Zurich Establish Joint Laboratory on Nano-technology for Gastrointestinal and Cardiovascular Diseases

CUHK-DGIST-ETH Zurich Establish Joint Laboratory on Nano-technology for Gastrointestinal and Cardiovascular Diseases

International collaboration
CUHK Completes a 20,000-person Plasma DNA Screening Study of Nasopharyngeal Cancer, and Finds a Dramatic Shift to Early Stage Cancers

CUHK Completes a 20,000-person Plasma DNA Screening Study of Nasopharyngeal Cancer, and Finds a Dramatic Shift to Early Stage Cancers

Research
CUHK and ETH Zurich Forge an Alliance on Innovative Technologies for Gastrointestinal Diseases

CUHK and ETH Zurich Forge an Alliance on Innovative Technologies for Gastrointestinal Diseases

International collaboration
‘Science is an Integral Part of My Life’ CUHK’s Prof. Dennis Lo Reaps Inaugural Future Science Prize

‘Science is an Integral Part of My Life’ CUHK’s Prof. Dennis Lo Reaps Inaugural Future Science Prize

Awards and honors
CUHK Professor Dennis Lo Named ‘Thomson Reuters Citation Laureate’, an Honour Considered as an Index to Predict Nobel Prize Winners

CUHK Professor Dennis Lo Named ‘Thomson Reuters Citation Laureate’, an Honour Considered as an Index to Predict Nobel Prize Winners

Awards and honors
CUHK Professor Dennis Lo Receives Future Science Prize – Life Science Prize, the China's Nobel Prize

CUHK Professor Dennis Lo Receives Future Science Prize – Life Science Prize, the China's Nobel Prize

Awards and honors
CUHK World’s First Study Confirms A New Colorectal Cancer High Risk Group

CUHK World’s First Study Confirms A New Colorectal Cancer High Risk Group

Research
CUHK Sets up the Global First Research Registry on Early Onset Dementia in Chinese Population

CUHK Sets up the Global First Research Registry on Early Onset Dementia in Chinese Population

Research
CUHK Launches ‘Lui Che Woo Distinguished Young Scholars Award’ Over HKD 15 Million Worth of Scholarship to Support Medical Students’ Pursuit of Postgraduate Research Overseas

CUHK Launches ‘Lui Che Woo Distinguished Young Scholars Award’ Over HKD 15 Million Worth of Scholarship to Support Medical Students’ Pursuit of Postgraduate Research Overseas

Donation
CUHK Pao So Kok Macular Disease Treatment and Research Centre Opens Study Sees Correlation between Protein Angiopoietin2 and Wet Age-related Macular Degeneration

CUHK Pao So Kok Macular Disease Treatment and Research Centre Opens Study Sees Correlation between Protein Angiopoietin2 and Wet Age-related Macular Degeneration

Donation
CUHK Launches Newborn Add-on Test for Congenital Adrenal Hyperplasia Supported by Joshua Hellmann Foundation for Orphan Disease

CUHK Launches Newborn Add-on Test for Congenital Adrenal Hyperplasia Supported by Joshua Hellmann Foundation for Orphan Disease

Donation
CUHK Screening Reveals 1 in 3 Older Adults in Community Suffer Brain Small Vessel Disease, Early Prevention Recommended

CUHK Screening Reveals 1 in 3 Older Adults in Community Suffer Brain Small Vessel Disease, Early Prevention Recommended

Clinical service
CUHK Professor Dennis Lo as the First Chinese Honoured with AACC Wallace H. Coulter Lectureship Award

CUHK Professor Dennis Lo as the First Chinese Honoured with AACC Wallace H. Coulter Lectureship Award

Awards and honors
The Chinese University of Hong Kong and Imperial College Collaborate on Healthcare Innovation and Biomedical Robotics

The Chinese University of Hong Kong and Imperial College Collaborate on Healthcare Innovation and Biomedical Robotics

International collaboration
CUHK Professor Dennis Lo Received International Honour for Pioneering Research in Personalized Medicine

CUHK Professor Dennis Lo Received International Honour for Pioneering Research in Personalized Medicine

Awards and honors
CUHK Succeeds in Treating Gastroesophageal Reflux Disease by Implantable Pulse Generator

CUHK Succeeds in Treating Gastroesophageal Reflux Disease by Implantable Pulse Generator

Surgical advancement
CUHK Introduces Asia's First "Gastric Pacemaker" To Restore Digestive Function in Gastroparesis Patients

CUHK Introduces Asia's First "Gastric Pacemaker" To Restore Digestive Function in Gastroparesis Patients

Surgical advancement
Factsheet on Personalised Medicine (Only available in Chinese Version)

Factsheet on Personalised Medicine (Only available in Chinese Version)

Research
CUHK Professor Dennis Lo Awarded King Faisal International Prize for Medicine

CUHK Professor Dennis Lo Awarded King Faisal International Prize for Medicine

Awards and honors
CUHK Launches Territory-wide Screening Study for Early Detection of Nasopharynx Cancer Now Recruiting 20,000 Citizens to Join

CUHK Launches Territory-wide Screening Study for Early Detection of Nasopharynx Cancer Now Recruiting 20,000 Citizens to Join

Research
CUHK and Joshua Hellmann Foundation for Orphan Disease Jointly Launch Territory’s First Newborn Metabolic Screening Program

CUHK and Joshua Hellmann Foundation for Orphan Disease Jointly Launch Territory’s First Newborn Metabolic Screening Program

Donation
CUHK Research Pioneer in Non-invasive Prenatal Diagnosis Elected to US National Academy of Sciences

CUHK Research Pioneer in Non-invasive Prenatal Diagnosis Elected to US National Academy of Sciences

Awards and honors
CUHK Held Naming Ceremony of the Lui Che Woo Clinical Sciences Building Today

CUHK Held Naming Ceremony of the Lui Che Woo Clinical Sciences Building Today

Milestone
The Lee Wing Kit Advanced Ophthalmic Training and Education Centre Opens Today

The Lee Wing Kit Advanced Ophthalmic Training and Education Centre Opens Today

Donation
CUHK Lo Kwee-Seong Integrated Biomedical Sciences Building Opened

CUHK Lo Kwee-Seong Integrated Biomedical Sciences Building Opened

Milestone
CUHK Launches Non-invasive Prenatal Test for Down Syndrome 15 Years of Research Comes to Fruition

CUHK Launches Non-invasive Prenatal Test for Down Syndrome 15 Years of Research Comes to Fruition

Research
CUHK's Youth Urological Treatment Centre Opens Today Territory's First Centre to Provide Urological Assessment and Treatment to Young Drug Abusers

CUHK's Youth Urological Treatment Centre Opens Today Territory's First Centre to Provide Urological Assessment and Treatment to Young Drug Abusers

Donation
CUHK Successfully Performed Hong Kong's First Robotic Endoscopic Scarless Surgery - A Major Endoscopic Technological Breakthrough

CUHK Successfully Performed Hong Kong's First Robotic Endoscopic Scarless Surgery - A Major Endoscopic Technological Breakthrough

Surgical advancement
CUHK Pioneers Scarless Per-oral Endoscopic Myotomy for Treatment of Esophageal Motility Disorders in Hong Kong

CUHK Pioneers Scarless Per-oral Endoscopic Myotomy for Treatment of Esophageal Motility Disorders in Hong Kong

Surgical advancement

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.